ALX Oncology Holdings Inc — Cash Flow (NASDAQ:ALXO) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 38.29 M68.1 M89.22 M130.36 M121.91 M 97.21 M Cash from investing activities 610 K4.92 M235.42 M44.66 M86.26 M 104.54 M Cash from financing activities 462.88 M2.47 M9.86 M59.29 M30.82 M 644 K Free cash flow 38.26 M67.44 M87.8 M129.09 M121.47 M 96.98 M

ニュース

Brightspring Health Services, BASF, Swiss Re and more set to report Friday

Is Teva Pharmaceutical Industries (TEVA) Outperforming Other Medical Stocks This Year?

Is ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?

ALXオンコロジー、1株1.57ドルで1億5000万ドルの株式公募価格を決定

ALX Oncology prices $150 million stock offering at $1.57 per share

ALX Oncologyが乳がん治験でCD47バイオマーカーの知見を報告

ALX Oncology reports CD47 biomarker findings in breast cancer trial

ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:ALXO) 2026-01-21

ALXオンコロジー、誘引型株式プランの予約株式数を増加

ALX Oncology increases shares reserved for inducement equity plan

ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Alxオンコロジー株、リンパ腫治療の印象的な結果を受けて急騰